Q1 26 EPS
$1.32
Q1 26 Revenue
$5.43B
BEAT +18.58%
Est. $4.58B
vs S&P Since Q1 26
+9.7%
BEATING MARKET
MO +10.0% vs S&P +0.3%
Market Reaction
Did MO Beat Earnings? Q1 2026 Results
Altria Group delivered a strong beat on both lines in Q1 2026, extending its streak of consensus EPS beats to four consecutive quarters as the tobacco giant posted adjusted diluted EPS of $1.32, clearing the $1.25 consensus estimate by 5.92%, while r… Read more Altria Group delivered a strong beat on both lines in Q1 2026, extending its streak of consensus EPS beats to four consecutive quarters as the tobacco giant posted adjusted diluted EPS of $1.32, clearing the $1.25 consensus estimate by 5.92%, while revenue of $5.43 billion topped expectations by 18.58% and grew 20.1% year over year. The headline revenue surge was driven in large part by the introduction of contract manufactured export cigarettes, a new activity that added 610 million sticks to shipment volumes, alongside continued pricing strength in the smokeable products segment, where adjusted operating companies income rose 6.3% to $2.68 billion and margins expanded to 65.1%. Growth was partially offset by Marlboro's retail share slipping 1.4 points to 39.7% and mounting competition in nicotine pouches, where on!'s category share fell to 13.4%. Looking ahead, Altria reaffirmed its full-year 2026 adjusted diluted EPS guidance of $5.56 to $5.72, reflecting 2.5% to 5.5% growth, with management now expecting a more balanced earnings cadence across both halves of the year.
Key Takeaways
- • Higher pricing across smokeable and oral tobacco segments
- • Refunds of taxes and duties paid on imported cigarettes in 2026
- • Fewer shares outstanding contributing to adjusted diluted EPS growth
- • Marlboro strengthened its position in the premium cigarette segment with 59.5% share
- • on! nicotine pouch shipment volume grew 17.6%
- • Introduction of contract manufactured export cigarettes (610 million sticks)
MO Forward Guidance & Outlook
Altria reaffirmed full-year 2026 adjusted diluted EPS guidance of $5.56 to $5.72, representing 2.5% to 5.5% growth from a 2025 base of $5.42. Following strong Q1 performance, the company now expects adjusted diluted EPS growth to be more balanced between the first half and second half of the year. The reaffirmed guidance incorporates the impact of moderated e-vapor industry growth on combustible and e-vapor product volumes and increased macroeconomic uncertainty facing adult nicotine consumers. Additional assumptions include a progressive increase in cigarette import and export activity over the course of the year, planned investments in contract manufacturing capabilities, the expectation that NJOY ACE does not return to the marketplace in 2026, reinvestment of anticipated cost savings from the Optimize & Accelerate initiative, and planned investments in support of the company's Vision.
MO YoY Financials
Q1 2026 vs Q1 2025, source: SEC Filings
MO Revenue by Segment
With YoY comparisons, source: SEC Filings
“We delivered a strong start to the year, growing adjusted diluted EPS by 7.3% in the first quarter. Our highly cash-generative businesses supported significant returns to shareholders through dividends and share repurchases, while we continued to invest in support of our Vision.”
— Billy Gifford, Q1 2026 Earnings Press Release
MO Earnings Trends
MO vs Market 30 Day Price Reactions
30-day stock return vs benchmark after each earnings
MO EPS Trend
Earnings per share: estimate vs actual
MO Revenue Trend
Quarterly revenue: estimate vs actual
MO Quarterly Results
5 quarters of earnings data
| Quarter | EPS Est. | EPS Act. | Surprise | Revenue | Rev. Surprise |
|---|---|---|---|---|---|
| Q1 26 | — | $1.32 | — | $5.43B | +18.58% |
| Q4 25 BEAT FY | $1.25 | $1.30 | +4.39% | $5.85B | +27.85% |
| FY Full Year | — | $5.42 | — | $23.28B | — |
| Q3 25 BEAT | $1.45 | $1.45 | +0.12% | $5.25B | -1.05% |
| Q2 25 BEAT | $1.38 | $1.44 | +3.99% | $5.29B | +1.94% |
| Q1 25 BEAT | $1.19 | $1.23 | +3.53% | $5.26B | +13.95% |